Ayaz Yktiyarov

Dr. Ayaz Yktiyarov


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
AUAigul Maratovna Utegenova
Aigul Maratovna Utegenova
LKLazzat Kassayeva
Lazzat Kassayeva
BTBayan Turdalina
Bayan Turdalina
ABAliya Baiduissenova
Aliya Baiduissenova
Ayaz YktiyarovAyaz Yktiyarov
Ayaz Yktiyarov
ESEvgeni Sokurenko
Evgeni Sokurenko
Latent tuberculosis infection (LTBI) represents a major global health concern as it constitutes the principal reservoir for future tuberculosis (TB) disease. Its identification is particularly important in Bacille Calmette–Guérin (BCG)-vaccinated populations, where cross-reactivity of purified protein derivative limits the specificity of the tuberculin skin test and hampers targeted preventive therapy. Early Mycobacterium tuberculosis antigens encoded within the RD1 region, especially ESAT-6, CFP-10 and TB7.7, have enabled the development of antigen-specific interferon-gamma release assays (IGRAs) and recombinant skin tests with improved BCG-independent specificity. This narrative review integrates and critically appraises current evidence on the immunobiological properties of early and latency-associated antigens, the cellular mechanisms underlying T-cell-dependent immune reactivity, and the diagnostic performance of IGRAs and ESAT-6/CFP-10-based skin tests, rather than merely summarizing individual studies. Although these platforms rely on different assay principles (in vitro cytokine release versus in vivo delayed-type hypersensitivity), both measure antigen-specific T-cell memory and do not define the biological stage of infection or reliably distinguish latent from incipient or active TB. Across most adult populations, IGRAs demonstrate high specificity and acceptable sensitivity, whereas reduced sensitivity and higher rates of indeterminate results are observed in young children and immunocompromised individuals. ESAT-6/CFP-10-based skin tests show diagnostic accuracy comparable to IGRAs and may offer operational advantages in resource-limited settings. Latency-associated antigens and host biomarkers such as IP-10, together with multi-analyte immune signatures, represent promising avenues for improving diagnostic sensitivity and prognostic stratification but currently lack sufficient validation for routine clinical use. Overall, RD1-encoded antigens remain central to LTBI immunodiagnosis, while future research should focus on developing stage-resolving and prognostic biomarkers, optimized antigen panels, and standardized interpretive frameworks.

2 April 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
NSNazgul Sutimbekova
Nazgul Sutimbekova
NBNelya Bissenova
Nelya Bissenova
MDMarat Dusmagambetov
Marat Dusmagambetov
USUlbossyn Saltabayeva
Ulbossyn Saltabayeva
AUAigul Maratovna Utegenova
Aigul Maratovna Utegenova
ESEvgeni Sokurenko
Evgeni Sokurenko
Acinetobacter baumannii has emerged as one of the most challenging opportunistic pathogens in modern healthcare due to its remarkable ability to acquire and disseminate antimicrobial resistance determinants. Carbapenem-resistant A. baumannii (CRAB) is now recognized by the World Health Organization as a critical priority pathogen, highlighting the urgent need for improved diagnostic, surveillance, and therapeutic strategies. This review synthesizes current evidence on the relationship between phenotypic antimicrobial susceptibility patterns and underlying genetic determinants of resistance in A. baumannii. A structured literature search was conducted across major biomedical databases (PubMed/MEDLINE, Scopus, Web of Science, and the Cochrane Library), supplemented by citation tracking and relevant institutional sources, focusing on studies published between 2016 and 2026. The analysis integrates findings from studies examining phenotypic antimicrobial susceptibility testing (AST) with molecular and genomic investigations of resistance mechanisms, including carbapenemases, aminoglycoside-modifying enzymes, efflux pumps, and resistance-associated genomic islands. Particular attention is given to the complex and sometimes discordant relationship between genotype and phenotype, where the presence of resistance genes does not always translate directly into phenotypic resistance due to regulatory mechanisms, gene expression variability, and genomic context. The review further discusses methodological differences in AST standards and genomic prediction approaches that may contribute to variability across studies. Collectively, the evidence supports a multidimensional interpretation of antimicrobial resistance in A. baumannii, emphasizing the necessity of integrating phenotypic and genotypic data for accurate diagnostics, surveillance, and clinical decision-making. This integrated perspective may contribute to improved understanding of resistance evolution and support the development of more effective strategies for managing multidrug-resistant A. baumannii infections.

27 February 2026 in Astana Medical Journal
Verified
Journal Article
Open access
PDF file
MDMarzhan Dosmagambetova
Marzhan Dosmagambetova
AYAigul Yskakova
Aigul Yskakova
ABAliya Baiduissenova
Aliya Baiduissenova
Ayaz YktiyarovAyaz Yktiyarov
Ayaz Yktiyarov
Mukhtar TultabayevMukhtar Tultabayev
Mukhtar Tultabayev
DKDauren Kulbatyrov
Dauren Kulbatyrov
Healthcare-associated infections remain one of the leading causes of morbidity and economic burden worldwide, with the contact route of transmission via contaminated hands of healthcare workers recognized as the principal mechanism of pathogen spread. Hand antisepsis is therefore considered a core component of infection prevention and control programs, and the effectiveness of antiseptic agents is determined not only by their antimicrobial spectrum but also by the kinetics of action, residual activity, dosage form, and tolerability during repeated use. This narrative review with elements of a systematic search summarizes current evidence on alcohol-based gel skin antiseptics for hand hygiene of healthcare workers in the prevention of healthcare-associated infections, with a particular focus on combined formulations containing cationic antiseptics, organic acids, and emollient components. Clinical and experimental studies, as well as international guidelines and standards, addressing antimicrobial and antiviral activity, prolonged effect, and dermatological tolerability of gel-based antiseptics are analyzed. The available data indicate that the combination of ethanol with quaternary ammonium compounds and organic acids provides synergistic bactericidal and virucidal activity against major healthcare-associated pathogens and contributes to residual antimicrobial effects. The gel dosage form increases the contact time of active substances with the skin and optimizes the kinetics of antiseptic action compared with liquid solutions. Evidence from dermatological and infection control literature supports the role of emollient and lipid-replenishing components in preserving the skin barrier, preventing dryness and irritation, and maintaining physiological skin pH, which are critical determinants of user acceptability and compliance with hand hygiene protocols. Particular attention is given to safflower oil as a source of linoleic acid and tocopherols, which contribute to restoration of the stratum corneum lipid matrix and reduction of transepidermal water loss, thereby potentially improving tolerability and adherence to hand hygiene practices. Keywords: healthcare-associated infections, hand hygiene, skin antisepsis, safflower oil, alcohol-based hand rubs, skin barrier, emollients, infection control.